White-matter changes on MRI as surrogate marker

Philip Scheltens; Frederik Barkhof; Franz Fazekas

doi:https://doi.org/10.1017/S104161020300930X

White-matter changes on MRI as surrogate marker

Philip Scheltens, Frederik Barkhof, Franz Fazekas

Research output: Contribution to journal › Article › Academic › peer-review

1 Citation (Scopus)

Abstract

This article reviews the use of white-matter changes as identified on MRI as a surrogate marker in clinical trials on vascular dementia. As of yet, insufficient evidence is present to implement rating or volumetric assessment of the burden of white-matter changes as surrogate marker in such trials, in view of the limited sensitivity to change of current methods and the high measurement error.

Original language	English
Pages (from-to)	261-265
Number of pages	5
Journal	International psychogeriatrics
Volume	15
Issue number	SUPPL. 1
DOIs	https://doi.org/10.1017/S104161020300930X
Publication status	Published - 7 Oct 2003

Keywords

Clinical trials
Dementia
MRI
Vascular
White matter
pH

Access to Document

https://doi.org/10.1017/S104161020300930X

Cite this

@article{12e18ce951884455a3409dc397070e42,

title = "White-matter changes on MRI as surrogate marker",

abstract = "This article reviews the use of white-matter changes as identified on MRI as a surrogate marker in clinical trials on vascular dementia. As of yet, insufficient evidence is present to implement rating or volumetric assessment of the burden of white-matter changes as surrogate marker in such trials, in view of the limited sensitivity to change of current methods and the high measurement error.",

keywords = "Clinical trials, Dementia, MRI, Vascular, White matter, pH",

author = "Philip Scheltens and Frederik Barkhof and Franz Fazekas",

year = "2003",

month = oct,

day = "7",

doi = "https://doi.org/10.1017/S104161020300930X",

language = "English",

volume = "15",

pages = "261--265",

journal = "Psychogeriatrics",

issn = "1346-3500",

publisher = "Wiley",

number = "SUPPL. 1",

}

TY - JOUR

T1 - White-matter changes on MRI as surrogate marker

AU - Scheltens, Philip

AU - Barkhof, Frederik

AU - Fazekas, Franz

PY - 2003/10/7

Y1 - 2003/10/7

N2 - This article reviews the use of white-matter changes as identified on MRI as a surrogate marker in clinical trials on vascular dementia. As of yet, insufficient evidence is present to implement rating or volumetric assessment of the burden of white-matter changes as surrogate marker in such trials, in view of the limited sensitivity to change of current methods and the high measurement error.

AB - This article reviews the use of white-matter changes as identified on MRI as a surrogate marker in clinical trials on vascular dementia. As of yet, insufficient evidence is present to implement rating or volumetric assessment of the burden of white-matter changes as surrogate marker in such trials, in view of the limited sensitivity to change of current methods and the high measurement error.

KW - Clinical trials

KW - Dementia

KW - MRI

KW - Vascular

KW - White matter

KW - pH

UR - http://www.scopus.com/inward/record.url?scp=0141596215&partnerID=8YFLogxK

U2 - https://doi.org/10.1017/S104161020300930X

DO - https://doi.org/10.1017/S104161020300930X

M3 - Article

C2 - 16191251

SN - 1346-3500

VL - 15

SP - 261

EP - 265

JO - Psychogeriatrics

JF - Psychogeriatrics

IS - SUPPL. 1

ER -

White-matter changes on MRI as surrogate marker

Abstract

Keywords

Access to Document

Other files and links

Cite this